Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin vs Combinations for MRSA Bacteremia
NCT00304811Phase 4Completed
- Sponsor
- Michael E. DeBakey VA Medical Center
- Start
- Jan 2006
- Primary completion
- Jan 2007
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gentamicin and rifampicin in Staphylococcus aureus infection (4 arms), sponsored by Michael E. DeBakey VA Medical Center. Primary endpoints: Time to defervescence (24 hours of temperature <100 degrees F), Return of WBC to normal (<10,500) and 2 more. Started Jan 2006; status: completed.
02
Drugs
gentamicinrifampicin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00304811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304811.